Direct and indirect contribution of human embryonic stem cell-derived hepatocyte-like cells to liver repair in mice
- PMID: 22138358
- DOI: 10.1053/j.gastro.2011.11.030
Direct and indirect contribution of human embryonic stem cell-derived hepatocyte-like cells to liver repair in mice
Abstract
Background & aims: Many studies of embryonic stem cells have investigated direct cell replacement of damaged tissues, but little is known about how donor cell-derived signals affect host tissue regeneration. We investigated the direct and indirect roles of human embryonic stem cell-derived cells in liver repair in mice.
Methods: To promote the initial differentiation of human embryonic stem cells into mesendoderm, we activated the β-catenin signaling pathway with lithium; cells were then further differentiated into hepatocyte-like cells. The differentiated cells were purified by indocyanine green staining and laser microdissection and characterized by immunostaining, polymerase chain reaction, biochemical function, electron microscopy, and transplantation analyses. To investigate indirect effects of these cells, secreted proteins (secretomes) were analyzed by a label-free quantitative mass spectrometry. Carbon tetrachloride was used to induce acute liver injury in mice; cells or secreted proteins were administered by intrasplenic or intraperitoneal injection, respectively.
Results: The differentiated hepatocyte-like cells had multiple features of normal hepatocytes, engrafted efficiently into mice, and continued to have hepatic features; they promoted proliferation of host hepatocytes and revascularization of injured host liver tissues. Proteomic analysis identified proteins secreted from these cells that might promote host tissue repair. Injection of the secreted proteins into injured livers of mice promoted significant amounts of tissue regeneration without cell grafts.
Conclusions: Hepatocyte-like cells derived from human embryonic stem cells contribute to recovery of injured liver tissues in mice, not only by cell replacement but also by delivering trophic factors that support endogenous liver regeneration.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.Liver Transpl. 2010 Oct;16(10):1195-206. doi: 10.1002/lt.22136. Liver Transpl. 2010. PMID: 20879018
-
Potentials of Differentiated Human Cord Blood-Derived Unrestricted Somatic Stem Cells in Treatment of Liver Cirrhosis.Exp Clin Transplant. 2019 Apr;17(2):251-258. doi: 10.6002/ect.2017.0249. Epub 2018 Oct 19. Exp Clin Transplant. 2019. PMID: 30346265
-
Transplant of Hepatocytes, Undifferentiated Mesenchymal Stem Cells, and In Vitro Hepatocyte-Differentiated Mesenchymal Stem Cells in a Chronic Liver Failure Experimental Model: A Comparative Study.Exp Clin Transplant. 2018 Feb;16(1):81-89. doi: 10.6002/ect.2016.0226. Epub 2017 Jun 5. Exp Clin Transplant. 2018. PMID: 28585911
-
Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.Arch Toxicol. 2016 Sep;90(9):2049-2061. doi: 10.1007/s00204-016-1756-1. Epub 2016 Jun 20. Arch Toxicol. 2016. PMID: 27325232 Review.
-
Thinking outside the liver: induced pluripotent stem cells for hepatic applications.World J Gastroenterol. 2013 Jun 14;19(22):3385-96. doi: 10.3748/wjg.v19.i22.3385. World J Gastroenterol. 2013. PMID: 23801830 Free PMC article. Review.
Cited by
-
The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology.Clin Mol Hepatol. 2022 Oct;28(4):706-724. doi: 10.3350/cmh.2021.0390. Epub 2022 Mar 2. Clin Mol Hepatol. 2022. PMID: 35232008 Free PMC article. Review.
-
Stem Cell-based Therapy Strategy for Hepatic Fibrosis by Targeting Intrahepatic Cells.Stem Cell Rev Rep. 2022 Jan;18(1):77-93. doi: 10.1007/s12015-021-10286-9. Epub 2021 Oct 19. Stem Cell Rev Rep. 2022. PMID: 34668120 Review.
-
Stem Cell-Based Therapies for Liver Diseases: An Overview and Update.Tissue Eng Regen Med. 2019 Feb 21;16(2):107-118. doi: 10.1007/s13770-019-00178-y. eCollection 2019 Apr. Tissue Eng Regen Med. 2019. PMID: 30989038 Free PMC article. Review.
-
Leveraging stem cells to combat hepatitis: a comprehensive review of recent studies.Mol Biol Rep. 2024 Mar 29;51(1):459. doi: 10.1007/s11033-024-09391-y. Mol Biol Rep. 2024. PMID: 38551743 Review.
-
Functional hit 1 (FH1)-based rapid and efficient generation of functional hepatocytes from human mesenchymal stem cells: a novel strategy for hepatic differentiation.Ann Transl Med. 2021 Jul;9(13):1087. doi: 10.21037/atm-21-2829. Ann Transl Med. 2021. PMID: 34422999 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
